MedMira Inc. (MIR)

TSX Venture Exchange | Biotech | Rapid diagnostic tests
Free
No email, no account, no signup.
Pulling latest news for MedMira Inc.…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
TSX Venture Exchange
Type
Biotech
Sector
Rapid diagnostic tests
Market Cap
$5M
We're already tracking MedMira Inc. — here are the latest events we've registered

Recent News

  • In April 2024, MedMira announced the extension of its existing debt facilities to support ongoing operations and product commercialization. The company is currently focused on the commercialization of its Multiplo platform for the simultaneous detection of multiple pathogens.
Want to know how this news affects MedMira Inc.? Order the analysis.
Order analysis – $4.99

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of MedMira Inc. will be delivered in the same format.
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
MedMira Inc. (MIR)
Fresh analysis on demand
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.